TW325468B - Process for making phenyl heterocycles useful as cox-2 inhibitors - Google Patents

Process for making phenyl heterocycles useful as cox-2 inhibitors

Info

Publication number
TW325468B
TW325468B TW084109387A TW84109387A TW325468B TW 325468 B TW325468 B TW 325468B TW 084109387 A TW084109387 A TW 084109387A TW 84109387 A TW84109387 A TW 84109387A TW 325468 B TW325468 B TW 325468B
Authority
TW
Taiwan
Prior art keywords
compound
coupling
formula
cox
inhibitors
Prior art date
Application number
TW084109387A
Other languages
English (en)
Inventor
Desmond Richard
Dolling Ulf
Marcune Ben
Tilyer Richard
Tschaen David
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of TW325468B publication Critical patent/TW325468B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
TW084109387A 1994-09-16 1995-09-08 Process for making phenyl heterocycles useful as cox-2 inhibitors TW325468B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/307,972 US5585504A (en) 1994-09-16 1994-09-16 Process of making cox-2 inhibitors having a lactone bridge

Publications (1)

Publication Number Publication Date
TW325468B true TW325468B (en) 1998-01-21

Family

ID=23191976

Family Applications (1)

Application Number Title Priority Date Filing Date
TW084109387A TW325468B (en) 1994-09-16 1995-09-08 Process for making phenyl heterocycles useful as cox-2 inhibitors

Country Status (12)

Country Link
US (1) US5585504A (zh)
CN (1) CN1065533C (zh)
AU (1) AU3510595A (zh)
BR (1) BR9508927A (zh)
CZ (1) CZ288797B6 (zh)
FI (1) FI106376B (zh)
RO (1) RO118585B1 (zh)
RU (1) RU2160257C2 (zh)
SK (1) SK282789B6 (zh)
TW (1) TW325468B (zh)
UA (1) UA49809C2 (zh)
WO (1) WO1996008482A1 (zh)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2747123B1 (fr) * 1996-04-04 1998-06-26 Union Pharma Scient Appl Nouveaux derives diarylmethylidene tetrahydrofurane, leurs procedes de preparation, et leurs utilisations en therapeutique
US6180651B1 (en) * 1996-04-04 2001-01-30 Bristol-Myers Squibb Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics
US5807873A (en) * 1996-04-04 1998-09-15 Laboratories Upsa Diarylmethylidenefuran derivatives and their uses in therapeutics
US5883267A (en) * 1996-05-31 1999-03-16 Merck & Co., Inc. Process for making phenyl heterocycles useful as cox-2 inhibitors
HRP970289A2 (en) * 1996-05-31 1998-04-30 Merck & Co Inc Process for preparing phenyl heterocycles useful as cox-2 inhibitors
US5985930A (en) 1996-11-21 1999-11-16 Pasinetti; Giulio M. Treatment of neurodegenerative conditions with nimesulide
US6200760B1 (en) 1997-02-24 2001-03-13 Cornell Research Foundation, Inc. Method of screening agents as candidates for drugs or sources of drugs
ES2201466T3 (es) * 1997-03-14 2004-03-16 MERCK FROSST CANADA & CO. `(metilsulfonil)fenil-2-(5h)-furanonas con enlace con oxigeno como inhibidores de cox-2`.
US6071954A (en) * 1997-03-14 2000-06-06 Merk Frosst Canada, Inc. (methylsulfonyl)phenyl-2-(5H)-furanones with oxygen link as COX-2 inhibitors
US6294558B1 (en) * 1999-05-31 2001-09-25 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
TNSN99111A1 (fr) * 1998-06-11 2005-11-10 Pfizer Derives de sulfonylbenzene nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
US6727238B2 (en) 1998-06-11 2004-04-27 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
DE60023119T2 (de) * 1999-03-10 2006-07-20 G.D. Searle Llc Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
ES2193921T3 (es) 1999-12-03 2003-11-16 Pfizer Prod Inc Compuestos de sulfamoilheteroaril-pirazol como agentes antinflamatorios/analgesicos.
TR200302047T4 (tr) 1999-12-03 2004-01-21 Pfizer Products Inc. Anti-iltihabik / analjezik maddeler olarak heteroaril fenil pirazol bileşikleri.
ATE291019T1 (de) 1999-12-03 2005-04-15 Pfizer Prod Inc Heterocyclo-alkylsulfonylpyrazolderivate zur verwendung als anti-imflammatorische oder analgetische verbindungen
DE60004001T2 (de) 1999-12-03 2004-04-15 Pfizer Products Inc., Groton Acetylenderivate zur Verwendung als schmerzstillendes oder entzündungshemmendes Mittel
PL351944A1 (en) 1999-12-08 2003-07-14 Pharmacia Corp Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
DE10012825B4 (de) 2000-03-16 2004-04-15 Bayer Corp. Verfahren zur Herstellung von spirocyclischen Tetronsäurederivaten
CN1102586C (zh) * 2000-04-07 2003-03-05 中国科学院上海有机化学研究所 β位含有芳基取代基的γ－丁烯酸内酯及其固相合成法
WO2002005848A2 (en) * 2000-07-13 2002-01-24 Pharmacia Corporation Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
AU2001285334A1 (en) * 2000-08-29 2002-03-13 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
US7695736B2 (en) 2001-04-03 2010-04-13 Pfizer Inc. Reconstitutable parenteral composition
EP1273582B1 (en) 2001-07-05 2005-06-29 Pfizer Products Inc. Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents
UA80682C2 (en) * 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
GT200200183A (es) 2001-09-28 2003-05-23 Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazol
WO2003037336A1 (en) 2001-11-02 2003-05-08 Pfizer Products Inc. 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
ES2213485B1 (es) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
ES2394782T3 (es) * 2003-05-07 2013-02-05 Osteologix A/S Composición con estroncio y vitamina D para la profilaxis y/o tratamiento de afecciones de cartílagos y/o huesos
PL1745791T3 (pl) * 2003-05-07 2013-11-29 Osteologix As Leczenie chorób chrząstki/kości za pomocą rozpuszczalnych w wodzie soli strontu
WO2005016906A1 (en) * 2003-08-14 2005-02-24 Shasun Chemicals And Drugs Limited Process for the manufacture of rofecoxib
WO2005044227A1 (en) * 2003-11-05 2005-05-19 Glenmark Pharmaceuticals Limited Topical pharmaceutical compositions
US20050100594A1 (en) * 2003-11-12 2005-05-12 Nilendu Sen Pharmaceutical formulation containing muscle relaxant and COX-II inhibitor
CA3119728A1 (en) 2018-11-21 2020-05-28 Tremeau Pharmaceuticals, Inc. Purified forms of rofecoxib, methods of manufacture and use
US10945992B1 (en) 2019-11-13 2021-03-16 Tremeau Pharmaceuticals, Inc. Dosage forms of rofecoxib and related methods
US11161833B1 (en) 2021-04-09 2021-11-02 Tremeau Pharmaceuticals, Inc. Deuterated etoricoxib, methods of manufacture, and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0759432A1 (en) * 1993-01-15 1997-02-26 G.D. Searle & Co. Use of medicaments containing 3,4-diaryl furans and analogs thereof for treating a skin-related condition
US5462939A (en) * 1993-05-07 1995-10-31 Sterling Winthrop Inc. Peptidic ketones as interleukin-1β-converting enzyme inhibitors
CA2180651A1 (en) * 1994-01-10 1995-07-13 Yves Ducharme Phenyl heterocycles as cox-2 inhibitors

Also Published As

Publication number Publication date
SK282789B6 (sk) 2002-12-03
RO118585B1 (ro) 2003-07-30
CN1159191A (zh) 1997-09-10
CZ79297A3 (en) 1997-07-16
UA49809C2 (uk) 2002-10-15
RU2160257C2 (ru) 2000-12-10
FI971104A (fi) 1997-03-14
US5585504A (en) 1996-12-17
CZ288797B6 (cs) 2001-09-12
WO1996008482A1 (en) 1996-03-21
CN1065533C (zh) 2001-05-09
BR9508927A (pt) 1997-12-30
FI106376B (fi) 2001-01-31
AU3510595A (en) 1996-03-29
FI971104A0 (fi) 1997-03-14
SK31697A3 (en) 1997-10-08

Similar Documents

Publication Publication Date Title
TW325468B (en) Process for making phenyl heterocycles useful as cox-2 inhibitors
ES8703142A1 (es) Proceso para preparar un derivado del bencimidazol.
TW369536B (en) Phosphonate nucleotide compounds
UA7140A1 (uk) Спосіб отримання похідних піридіну
CA2247748A1 (en) Resorcinol derivatives
EA200200481A1 (ru) Способ получения производных 4-трифторметилсульфинилпиразола
EP0687684A4 (en) COMPOUND ASSOCIATED WITH LEWIS SYSTEM, PROCESS FOR OBTAINING THIS COMPOUND AND ANTI-INFLAMMATORY
EP0825189A4 (en) 1,4-BENZODIOXIN DERIVATIVES
CA2402635A1 (en) Method for oxidizing a thioether group into a sulfoxide group
AU558433B2 (en) A fungicidal indanylbenzamide
AU8111398A (en) Benzothiophene derivative and corresponding use and composition
GR862463B (zh)
KR860001108A (ko) 페닐-나프티리딘의 제조방법
DE3569729D1 (en) 3-aminoazetidine, its salts, process for their preparation and intermediates
ES2131015A1 (es) Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas.
IL136739A (en) Diol compounds and processes for their preparation
GB9714302D0 (en) Process
ES8308329A1 (es) "un metodo de preparar derivados de oxotienobenzoxepina".
DK82583A (da) Furyloxazolyleddikesyrederivater og fremgangsmaader til fremstilling deraf
CO4940468A1 (es) Nuevos derivados de naftilpiperacina
AR002088A1 (es) Procedimiento para preparar 8-hidroxiquinolinas sustituidas.
PL337895A1 (en) Method of obtaining 2-alkylthiobenzonitrile derivatives
TW358087B (en) Method for preparing carbamoylmethylurea derivatives
ES8609243A1 (es) Un procedimiento para producir una indolina
EP1270549A4 (en) POLYMER IMMOBILIZED ALPHA IMINOESTER